The general awareness towards a sustainable life style is growing in society. This translates into a growing market for services and products that involve environment-friendly chemistry and material loops. Biotechnology will be on...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Información proyecto INCYPRO
Duración del proyecto: 18 meses
Fecha Inicio: 2019-01-16
Fecha Fin: 2020-07-31
Líder del proyecto
STICHTING VU
No se ha especificado una descripción o un objeto social para esta compañía.
TRL
4-5
Presupuesto del proyecto
150K€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
The general awareness towards a sustainable life style is growing in society. This translates into a growing market for services and products that involve environment-friendly chemistry and material loops. Biotechnology will be one the key drivers when aiming for a circular economy, as it facilitates green chemistry and efficient recycling processes. A central component of most biotechnological processes are biocatalytic proteins (so-called enzymes). However, enzymes are intrinsically vulnerable to elevated temperatures and unnatural microenvironments hampering their wide-spread use in production processes and consumer products. The stabilization of enzymes via small-molecular crosslinkers (INCYPRO), developed in the Grossmann lab, increases the robustness of enzymes towards conditions required for biotechnological applications. INCYPRO has the potential to improve current biotechnological processes and to allow completely new applications. As the method allows straight-forward and broad application, it is suitable for further valorization. In the proposed project, we will develop INCYPRO from its current method state into an innovative and valuable technology (Aim 1). We will further strengthen the intellectual property position (Aim 2) and develop a market valorization strategy (Aim 3). Our commercialization efforts are supported by experts from the private sector and the science-business interface.